S&P 500 (NYSE:SPY) component Life Technologies Corporation (NASDAQ:LIFE) will unveil its latest earnings on Thursday, July 28, 2011. Life Technologies Corporation is a global biotechnology tools company offering products that include systems, instruments, reagents and custom services.
Life Technologies Corporation Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of 94 cents per share, a rise of 3.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 97 cents. Between one and three months ago, the average estimate moved down and dropped from 95 cents during the last month. For the year, analysts are projecting profit of $3.87 per share, a rise of 9% from last year.
Past Earnings Performance: The company met estimates last quarter after beating the forecasts in the prior two. In the first quarter, the company reported net income of 85 cents per share versus a mean estimate of profit of 85 cents per share. In the fourth quarter of the last fiscal year, the company beat estimates by 4 cents.
Wall St. Revenue Expectations: On average, analysts predict $962.2 million in revenue this quarter, a rise of 6.3% from the year ago quarter. Analysts are forecasting total revenue of $3.81 billion for the year, a rise of 6.1% from last year’s revenue of $3.59 billion.
Analyst Ratings: Analysts are bullish on this stock with 11 analysts rating it as a buy, one rating it as a sell and four rating it as a hold.
The company has now seen net income rise in three straight quarters. In the first quarter, net income rose 2.4% while it rose 44.5% in the fourth quarter of the last fiscal year and more than twofold in the third quarter of the last fiscal year.
Revenue has risen the past four quarters. Revenue increased 1.2% to $895.9 million in first quarter. The figure rose 7% in the fourth quarter of the last fiscal year from the year earlier, climbed 8.3% in the third quarter of the last fiscal year from the year-ago quarter and 8.5% in the second quarter of the last fiscal year.
Competitors to Watch: Techne Corporation (NASDAQ:TECH), Qiagen NV (NASDAQ:QGEN), Affymetrix, Inc. (NASDAQ:AFFX), Sigma-Aldrich Corporation (NASDAQ:SIAL), Thermo Fisher Scientific Inc. (NYSE:TMO), Strategic Diagnostics Inc. (NASDAQ:SDIX), Agilent Technologies Inc. (NYSE:A), Bio-Rad Laboratories, Inc. (NYSE:BIO), PerkinElmer, Inc. (NYSE:PKI), and Johnson & Johnson (NYSE:JNJ).
Stock Price Performance: During April 25, 2011 to July 20, 2011, the stock price had fallen $3.88 (-7.3%) from $53.43 to $49.55. The stock price saw one of its best stretches over the last year between December 9, 2010 and December 16, 2010 when shares rose for six-straight days, rising 7.3% (+$3.81) over that span. It saw one of its worst periods between May 18, 2011 and May 27, 2011 when shares fell for eight-straight days, falling 4.9% (-$2.69) over that span. Shares are down $5.95 (-10.7%) year to date.
(Source: Xignite Financials)